Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BALAXI BALAXI PHARMACEUTICALS LIMITED Pharma · Small | AAREYDRUGS Aarey Drugs & Pharmaceuticals Limited Pharma · Small | ALPA Alpa Laboratories Limited Pharma · Small | JHS JHS Svendgaard Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 10 | 15 | 46 | 12 |
| Verdict | OVERVALUED | OVERVALUED | FAIR VALUE | OVERVALUED |
| Style | OVERVALUED | OVERVALUED | Deep Value | OVERVALUED |
| Piotroski | 3/9 | 6/9 | 6/9 | 3/9 |
| Valuation | 4/30 | 3/30 | 26/30 | 7/30 |
| Growth | 1/25 | 2/25 | 11/25 | 2/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 10/15 | 6/15 | 10/15 | 8/15 |
| Cash Flow | 1/10 | 4/10 | 4/10 | 2/10 |
| Price | ₹24.22 | ₹80.24 | ₹69.36 | ₹8.02 |
| P/E | 95.20 | 55.60 | 9.57 | — |
| P/B | 0.54 | 1.47 | 0.77 | 0.40 |
| ROE | 0.59% | 2.75% | 8.39% | -1.11% |
| ROCE | 3.11% | 5.58% | 9.42% | -0.78% |
| Debt / Equity | 0.23 | 0.33 | 0.02 | 0.09 |
| FCF Yield | — | — | — | — |
| Dividend Y | — | — | — | — |
| Altman Z | 3.06 | 3.33 | 3.25 | 2.39 |
| Promoter % | 65.99% | 37.71% | 57.19% | 33.85% |
| Mkt Cap (₹Cr) | 135.00 | 221.00 | 144.00 | 69.20 |
| Graham # | ₹16.24 | ₹40.86 | ₹119.15 | — |
| Fair PE | 0.9 | 4.2 | 42.0 | 2.6 |
| MoS % | -10731.4% | -1261.3% | +76.8% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBALAXI28
AAREYDRUGS125
ALPA61
JHS32